Search Within

Afruja Ahad

Formats
  1. Journal Article (7)
  2. Meeting Abstract (2)
Groups
  1. Radiochemistry and Imaging Sciences Service (7)
  2. Radiology, Department of (7)
  3. GSK Faculty (5)
  4. Molecular Imaging and Therapy Service (5)
  5. Sloan Kettering Institute Postdocs (5)
  6. Center for Molecular Imaging and Biotechnology (CMIB) (3)

More Groups

People
  1. Wolfgang Weber (4)
  2. Hanwen Zhang (3)
  3. Steven Larson (3)
  4. Alexa Michel (2)
  5. Jason Lewis (2)
  6. Meghan Bell (2)

More People

Years
  1. 2024 (2)
  2. 2023 (2)
  3. 2020 (1)
  4. 2018 (2)
  5. 2017 (2)
Publications
  1. Journal of Nuclear Medicine (3)
  2. ACS Pharmacology & Translational Science (2)
  3. Bioconjugate Chemistry (1)
  4. Chemistry - A European Journal (1)
  5. RSC Medicinal Chemistry (1)
  6. Theranostics (1)
Publishers
  1. American Chemical Society (3)
  2. Society of Nuclear Medicine (3)
  3. Ivyspring International Publisher (1)
  4. Royal Society of Chemistry (1)
  5. Wiley V C H Verlag Gmbh (1)

Results (9)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Insights into mechanisms and promising triple negative breast cancer therapeutic potential for a water-soluble ruthenium compound
    Journal Article

    Nayeem, N.; Sauma, S.; Ahad, A.; Rameau, R.; Kebadze, S.; Bazett, M.; Park, B. J.; Casaccia, P.; Prabha, S.; Hubbard, K.; more...
    ACS Pharmacology & Translational Science (2024)

    Fulltext@MSK | Save
  • Development of immunoliposomes containing cytotoxic gold payloads against HER2-positive breast cancers
    Journal Article

    Ahad, A.; Aftab, F.; Michel, A.; Lewis, J. S.; Contel, M.
    RSC Medicinal Chemistry (2024)

    Fulltext@MSK | Save
  • Shifting the antibody-drug conjugate paradigm: A trastuzumab-gold-based conjugate demonstrates high efficacy against human epidermal growth factor receptor 2-positive breast cancer mouse model
    Journal Article

    Ahad, A.; Saeed, H. K.; del Solar, V.; López-Hernández, J. E.; Michel, A.; Mathew, J.; Lewis, J. S.; Contel, M.
    ACS Pharmacology & Translational Science (2023)

    Fulltext@MSK | Save
  • Platinum(IV)–gold(I) agents with promising anticancer activity: Selected studies in 2D and 3D triple-negative breast cancer models
    Journal Article

    López-Hernández, J. E.; Nayeem, N.; Cerón-Carrasco, J. P.; Ahad, A.; Hafeez, A.; León, I. E.; Contel, M.
    Chemistry - A European Journal (2023)

    Fulltext@MSK | Save
  • Alpha radioimmunotherapy using (225)Ac-proteus-DOTA for solid tumors – Safety at curative doses
    Journal Article

    Cheal, S. M.; McDevitt, M. R.; Santich, B. H.; Patel, M.; Yang, G.; Fung, E. K.; Veach, D. R.; Bell, M.; Ahad, A.; Burnes Vargas, D.; more...
    Theranostics (2020)

    Fulltext@MSK | Save
  • Antibody with infinite affinity for in vivo tracking of genetically engineered lymphocytes
    Journal Article

    Krebs, S.; Ahad, A.; Carter, L. M.; Eyquem, J.; Brand, C.; Bell, M.; Ponomarev, V.; Reiner, T.; Meares, C. F.; Gottschalk, S.; more...
    Journal of Nuclear Medicine (2018)

    Fulltext@MSK | Save
  • Synthesis and evaluation of a novel (64)Cu- and (67)Ga-labeled neurokinin 1 receptor antagonist for in vivo targeting of NK1R-positive tumor xenografts
    Journal Article

    Zhang, H.; Kanduluru, A. K.; Desai, P.; Ahad, A.; Carlin, S.; Tandon, N.; Weber, W. A.; Low, P. S.
    Bioconjugate Chemistry (2018)

    Fulltext@MSK | Save
  • Optimization of bombesin antagonist for multi-modality imaging of GRP receptor expression in prostate cancer
    Meeting Abstract

    Zhang, H.; Yang, J.; Taunk, N.; Ahad, A.; Carlin, S.; Kircher, M.; Weber, W.
    Journal of Nuclear Medicine (2017)

    Fulltext@MSK | Save
  • Engineered DOTA antibody with infinite affinity for in vivo tracking of lymphocytes
    Meeting Abstract

    Krebs, S.; Zhang, H.; Ahad, A.; Zurita, J.; Shenker, L.; Larson, S.; Ponomarev, V.; Gottschalk, S.; Adusumilli, P.; Weber, W.
    Journal of Nuclear Medicine (2017)

    Fulltext@MSK | Save